References
Key articles
Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757-89.Full text Abstract
Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.Full text Abstract
Taylor-Robinson D. The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21:425-38. Abstract
Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372:835-45.Full text Abstract
Jacobs E. Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists. Euro Surveill. 2012;17:pii:20084.Full text Abstract
Esposito S, Bosis S, Begliatti E, et al. Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. Clin Infect Dis. 2006;43:206-9.Full text Abstract
Steinberg P, White RJ, Fuld SL, et al. Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina. Am J Epidemiol. 1969;89:62-73. Abstract
Neumayr L, Lennette E, Kelly D, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003;112:87-95. Abstract
Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137.Full text Abstract
Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.Full text Abstract
Reference articles
1. Pinto-Sander N, Soni S. Mycoplasma genitalium infection. BMJ. 2019 Oct 18;367:l5820.Full text Abstract
2. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757-89.Full text Abstract
3. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.Full text Abstract
4. Taylor-Robinson D. The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21:425-38. Abstract
5. Lowe J, Watkins WJ, Edwards MO, et al. Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis. Pediatr Infect Dis J. 2014;33:697-702. Abstract
6. Kupila L, Rantakokko-Jalava K, Jalava J, et al. Brain abscess caused by Mycoplasma hominis: a clinically recognizable entity? Eur J Neurol. 2006;13:550-1. Abstract
7. Cordtz J, Jensen JS. Disseminated Ureaplasma urealyticum infection in a hypo-gammaglobulinaemic renal transplant patient. Scand J Infect Dis. 2006;38:1114-7. Abstract
8. Miranda C, Camacho E, Reina G, et al. Isolation of Mycoplasma hominis from extragenital cultures. Eur J Clin Microbiol Infect Dis. 2005;24:334-7. Abstract
9. O'Sullivan MV, Isbel NM, Johnson DW, et al. Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction. Clin Infect Dis. 2004;39:e98-9.Full text Abstract
10. Zheng X, Olson DA, Tully JG, et al. Isolation of Mycoplasma hominis from a brain abscess. J Clin Microbiol. 1997;35:992-4.Full text Abstract
11. Johnson SM, Bruckner F, Collins D. Distribution of Mycoplasma pneumoniae and Mycoplasma salivarium in the synovial fluid of arthritis patients. J Clin Microbiol. 2007;45:953-7.Full text Abstract
12. Ramirez AS, Rosas A, Hernandez-Beriain JA, et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: a case-control study. Rheumatology (Oxford). 2005;44:912-4.Full text Abstract
13. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005;84:162-3. Abstract
14. Fenollar F, Gauduchon V, Casalta JP, et al. Mycoplasma endocarditis: two case reports and a review. Clin Infect Dis. 2004;38:e21-4.Full text Abstract
15. Paz A, Potasman I. Mycoplasma-associated carditis: case reports and review. Cardiology. 2002;97:83-8. Abstract
16. Yanez A, Cedillo L, Neyrolles O, et al. Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome. Emerg Infect Dis. 1999;5:164-7. Abstract
17. Witmer CM, Steenhoff AP, Shah SS, et al. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics. 2007;119:e292-5. Abstract
18. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372:835-45.Full text Abstract
19. Xu YC, Zhu LJ, Xu D, et al. Epidemiological characteristics and meteorological factors of childhood Mycoplasma pneumoniae pneumonia in Hangzhou. World J Pediatr. 2011;7:240-4. Abstract
20. Gadsby NJ, Reynolds AJ, McMenamin J, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011 - impact of the epidemic in infants. Euro Surveill. 2012;17:pii:20110.Full text Abstract
21. Chalker V, Stocki T, Litt D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012;17:pii:20081.Full text Abstract
22. Nir-Paz R, Abutbul A, Moses AE, et al. Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012;17:pii:20095.Full text Abstract
23. Uldum SA, Bangsborg JM, Gahrn-Hansen B, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012;17:pii:20073.Full text Abstract
24. Jacobs E. Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists. Euro Surveill. 2012;17:pii:20084.Full text Abstract
25. Pereyre S, Charron A, Hidalgo-Grass C, et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One. 2012;7:38585.Full text Abstract
26. Beeton ML, Zhang XS, Uldum SA, et al. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Euro Surveill. 2020 Jan;25(2):1900112.Full text Abstract
27. Esposito S, Bosis S, Begliatti E, et al. Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. Clin Infect Dis. 2006;43:206-9.Full text Abstract
28. Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10:e1001444.Full text Abstract
29. Ferguson GD, Gadsby NJ, Henderson SS, et al. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK. J Med Microbiol. 2013;62:1876-82. Abstract
30. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24:498-514.Full text Abstract
31. Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG. 2010;117:361-4. Abstract
32. Gaydos C, Maldeis NE, Hardick A, et al. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis. 2009;36:598-606. Abstract
33. Mavedzenge SN, Van Der Pol B, Weiss HA, et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS. 2012;26:617-24. Abstract
34. Vandepitte J, Muller E, Bukenya J, et al. Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis. 2012;205:289-96.Full text Abstract
35. Seña AC, Lee JY, Schwebke J, et al. A silent epidemic: the prevalence, incidence and persistence of Mycoplasma genitalium among young, asymptomatic high-risk women in the United States. Clin Infect Dis. 2018 Jun 18;67(1):73-9.Full text Abstract
36. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728. Abstract
37. Steinberg P, White RJ, Fuld SL, et al. Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina. Am J Epidemiol. 1969;89:62-73. Abstract
38. Wan GH, Huang CG, Huang YC, et al. Surveillance of airborne adenovirus and Mycoplasma pneumoniae in a hospital pediatric department. PLoS One. 2012;7:e33974.Full text Abstract
39. Daxboeck F, Khanakah G, Bauer C, et al. Detection of Mycoplasma pneumoniae in serum specimens from patients with Mycoplasma pneumonia by PCR. Int J Med Microbiol. 2005;295:279-285. Abstract
40. Katz B, Waites K. Emerging intracellular bacterial infections. Clin Lab Med. 2004;24:627-649. Abstract
41. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci USA. 2006;103:6724-6729. Abstract
42. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med. 2005;172:1078-1089. Abstract
43. Nakashima K, Tanaka T, Kramer MH, et al. Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000. Infect Control Hosp Epidemiol. 2006;27:1171-7. Abstract
44. Klement E, Talkington DF, Wasserzug O, et al. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis. 2006;43:1239-45. Abstract
45. Feikin DR, Moroney JF, Talkington DF, et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin Infect Dis. 1999;29:1545-50. Abstract
46. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-16. Abstract
47. Neumayr L, Lennette E, Kelly D, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003;112:87-95. Abstract
48. Klausner JD, Passaro D, Rosenberg J, et al. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. J Infect Dis. 1998;177:161-6.Full text Abstract
49. Hyde TB, Gilbert M, Schwartz SB. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis. 2001;183:907-12.Full text Abstract
50. Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(suppl 3):iii1-55.Full text Abstract
51. Loens K, Ieven M. Mycoplasma pneumoniae: current knowledge on nucleic acid amplification techniques and serological diagnostics. Front Microbiol. 2016;7:448.Full text Abstract
52. Diaz MH, Winchell JM. The evolution of advanced molecular diagnostics for the detection and characterization of Mycoplasma pneumoniae. Front Microbiol. 2016;7:232.Full text Abstract
53. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-67.Full text Abstract
54. Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019 Sep;30(10):938-50.Full text Abstract
55. Jensen JS, Cusini M, Gomberg M, et al. Background review for the 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1686-93.Full text Abstract
56. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137.Full text Abstract
57. Golden MR, Workowski KA, Bolan G. Developing a public health response to Mycoplasma genitalium. J Infect Dis. 2017 Jul 15;216(suppl_2):S420-6.Full text Abstract
58. Kim KW, Sung JJ, Tchah H, et al. Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study. Korean J Pediatr. 2015 Jun;58(6):211-7.Full text Abstract
59. British Thoracic Society. Annotated BTS guideline for the management of CAP in adults (2009): summary of recommendations. January 2015 [internet publication].Full text
60. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.Full text Abstract
61. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.Full text Abstract
62. Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother. 2009;53:2160-2.Full text Abstract
63. Averbuch D, Hidalgo-Grass C, Moses AE, et al. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011;17:1079-82.Full text Abstract
64. Peuchant O, Ménard A, Renaudin H, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64:52-8.Full text Abstract
65. Spuesens EB, Meijer A, Bierschenk D, et al. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in the Netherlands. J Clin Microbiol. 2012;50:1999-2004. Abstract
66. Brown RJ, Macfarlane-Smith L, Phillips S, et al. Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015. Euro Surveill. 2015;20:30078. Abstract
67. Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53:124-30. Abstract
68. Yamada M, Buller R, Bledsoe S, et al. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J. 2012;31:409-11. Abstract
69. Okada T, Morozumi M, Tajima T, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642-9. Abstract
70. Kawai Y, Miyashita N, Kubo M, et al. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother. 2013;57:2252-8. Abstract
71. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Nov 2018 [internet publication].Full text
72. Food and Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Mar 2018 [internet publication].Full text
73. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].Full text
74. Food and Drug Administration. FDA Drug Safety Communication: FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Jul 2018 [internet publication]Full text
75. Horner PJ, Blee K, Falk L, et al; International Union against Sexually Transmitted Infections. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016 Oct;27(11):928-37.Full text Abstract
76. Walker J, Fairley CK, Bradshaw CS, et al. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin Infect Dis. 2013;56:1094-100. Abstract
77. Touati A, Peuchant O, Jensen JS, et al. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol. 2014;52:1549-55. Abstract
78. Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015;60:1228-36.Full text Abstract
79. Pond MJ, Nori AV, Witney AA, et al. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis. 2014;58:631-7.Full text Abstract
80. Salado-Rasmussen K, Jensen JS. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis. 2014;59:24-30.Full text Abstract
81. Lau A, Bradshaw CS, Lewis D, et al. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. Clin Infect Dis. 2015 Nov 1;61(9):1389-99.Full text Abstract
82. Horner P, Ingle SM, Garrett F, et al. Which azithromycin regimen should be used for treating <i>Mycoplasma genitalium</i>? A meta-analysis. Sex Transm Infect. 2018 Feb;94(1):14-20.Full text Abstract
83. British for Sexual Health and HIV. Update to the 2015 BASHH UK national guideline on the management of non-gonococcal urethritis. Nov 2018 [internet publication].Full text
84. Kikuchi M, Ito S, Yasuda M, et al. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother. 2014;69:2376-82.Full text Abstract
85. Couldwell DL, Tagg KA, Jeoffreys NJ, et al. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS. 2013;24:822-8. Abstract
86. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709-712.Full text Abstract
87. Horner P, Ingle SM, Garrett F, et al. Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis. Sex Transm Infect. 2018 Feb;94(1):14-20.
88. Manhart LE, Jensen JS, Bradshaw CS, et al. Efficacy of antimicrobial therapy for Mycoplasma genitalium Infections. Clin Infect Dis. 2015;61(Suppl 8):S802-S817. Abstract
89. Horner P, Blee K, O'Mahony C, et al. 2015 UK national guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27:85-96.Full text Abstract
90. Read TRH, Jensen JS, Fairley CK, et al. Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection. Emerg Infect Dis. 2018 Feb;24(2):328-335.Full text Abstract
91. Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1650-1656.Full text Abstract
92. File TM, Goldberg L, Das A, et al. Efficacy and safety of intravenous-to-oral lefamulin, a pleuromutilin antibiotic, for the treatment of community-acquired bacterial pneumonia: the phase III lefamulin evaluation against pneumonia (LEAP 1) trial. Clin Infect Dis. 2019 Nov 13;69(11):1856-67.Full text Abstract
93. Alexander E, Goldberg L, Das AF, et al. Oral lefamulin vs moxifloxacin for early clinical response among adults with community-acquired bacterial pneumonia: the LEAP 2 randomized clinical trial. JAMA. 2019 Sep 27;322(17):1661-71.Full text Abstract
94. ClinicalTrials.gov. Study to compare delafloxacin to moxifloxacin for the treatment of adults with community-acquired bacterial pneumonia (DEFINE-CABP). NCT02679573. July 2019 [internet publication].Full text
95. Stets R, Popescu M, Gonong JR, et al. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med. 2019 Feb 7;380(6):517-27.Full text Abstract
96. Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis. 2008;198:1365-1374. Abstract
97. Kannan TR, Hardy RD, Coalson JJ, et al. Fatal outcomes in family transmission of Mycoplasma pneumoniae. Clin Infect Dis. 2012;54:225-231. Abstract
98. Scerpella EG, Whimbey EE, Champlin RE, et al. Pericarditis associated with Legionnaires' disease in a bone marrow transplant recipient. Clin Infect Dis. 1994;19:1168-1170. Abstract
99. Khoury T, Abu Rmeileh A, Kornspan JD, et al. Mycoplasma pneumoniae pneumonia associated with methemoglobinemia and anemia: an overlooked association? Open Forum Infect Dis. 2015;2:ofv022.Full text Abstract
100. Grullich C, Baumert TF, Blum HE. Acute Mycoplasma pneumoniae infection presenting as cholestatic hepatitis. J Clin Microbiol. 2003;41:514-515.Full text Abstract
101. Romero-Gomez M, Otero MA, Sanchez-Munoz D, et al. Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patients. J Hepatol. 2006;44:827-828. Abstract
102. Shuvy M, Rav-Acha M, Izhar U, et al. Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report. BMC Infect Dis. 2006;6:18. Abstract
103. Narita M, Tanaka H. Two distinct patterns of pleural effusions caused by Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2004;23:1069. Abstract
Use of this content is subject to our disclaimer